News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Core One Labs' Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and Other Drug Developers
Core One Labs Inc.
Silo Wellness Announces Portland-area Rural Oregon Psilocybin Service Center and Cultivation Real Estate Partner
Silo Wellness
Revive Therapeutics Ltd. Closes $4.3 Million Offering
Revive Therapeutics
Cybin Selects Generalized Anxiety Disorder as Target Indication for Deuterated DMT Molecule CYB004
Cybin Inc.
Algernon Pharmaceuticals Appoints Dr. Peter Dicpinigaitis to Chronic Cough Advisory Board
Algernon Pharmaceuticals
Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104
Reunion Neuroscience
Israel-Based Clearmind Medicine Successfully Completes Production of CMND-100 Drug Candidate for Clinical Trial
Clearmind Medicine
Cognetivity Neurosciences Provides Update on 2022 Corporate Achievements
Cognetivity Neurosciences
Irwin Naturals and Braxia Scientific Announce Partnership for In-Human Clinical Studies Supporting Pharmaceutical Companies in the US
Irwin Naturals
Braxia Scientific Corp.
Reunion Neuroscience Inc. Completes Interim Data Analysis for Phase 1 Clinical Trial with Novel Serotonergic Psychedelic RE104
Reunion Neuroscience
FSD Pharma Inc Incorporates New Subsidiary to Capitalize on Drug Development Incentives in Australia
FSD Pharma
First Patient Dosed in Small Pharma’s Phase I Study Exploring Intramuscular Administration of SPL026
Small Pharma
MindMed Provides Corporate Update and 2023 Outlook
Mind Medicine (MindMed)
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.